Newsletter | October 30, 2024

10.30.24 -- What Analytics Drive Process Intensification?

SPONSOR

With patient care increasingly moving into outpatient facilities and even the home, auto-injectors are an increasingly viable option for enabling patients and their caregivers to self-administer therapies. Auto-injection devices take the convenience of pre-filled syringes further by offering a comfortable and safe injection process. Identifying and collaborating with the right development and manufacturing partners can help companies design the right devices for their treatments and streamline the production process. Click here to read more.

FOCUS ON DOWNSTREAM MANUFACTURING

What Analytics Drive Process Intensification?

Bioprocess Online Live panelists discuss the most fundamental analytics that inform and enable process intensification strategies in this segment of Bioprocess Intensification In The Real World.

How Custom Media And Buffers Support CGT Development

In this presentation, experts emphasize the significance of optimized cell media and buffers in the production of cell and gene therapy products.

Understanding Viral Clearance During Anion-Exchange Chromatography

A design of experiments (DoE) study examined the anion-exchange process in general and to draw possible correlations between such properties and overall viral clearance capability.

Intensifying Downstream Bioprocessing With Continuous Technologies

Watch to explore intensified downstream bioprocessing in-depth and take the first step toward a more innovative and efficient future in bioprocessing.

Robust, Load Independent Viral Clearance In MAb Purification

How the Natrix Q chromatography membrane overcomes diffusion and binding capacity limitations and improved cost efficiency in a study measuring the removal of 4 model viruses.

NEW PODCAST EPISODE

Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright

Bill Enright has a knack for making big moves at inopportune times, then turning the expected outcome on its ear. He signed on as CEO at Altimmune when the company was struggling mightily. Enright had a turnaround plan, but as he was in the thick of a non-deal road show to execute said plan, Lehmen Brothers collapsed. On Business of Biotech, we'll learn how he flipped the script and other harrowing tales from the trenches.

DOWNSTREAM MANUFACTURING SOLUTIONS

Orthogonal Method For Testing RCAAV - Bio-Rad Laboratories, Inc.

Be A Gain Changer, 2x Throughput, Only With Supor Prime - Cytiva

A Conceptual Overview Of The BioSMB MCC Platform - Sartorius

Connect With Bioprocess Online: